Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Qualitative Health Research|June 23, 2020
The (Co)Production of Difference in the Care of Patients With Cancer From Migrant BackgroundsAlex Broom, Rhiannon Parker, Stephanie Raymond, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 11, 2014
Glioblastoma treatment in the elderly in the temozolomide therapy eraLinda Coate, Mairéad G McNamara, Zarnie Lwin, et al.
Asia-Pacific Journal of Clinical Oncology|April 9, 2026
Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre-Operative PD1 CheckpOint Blockade and Receptor Activator of NF-κB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC)-A Phase 1B/2 TrialElizabeth Ahern, Cassie Turner, Rishendran Naidoo, et al.
Journal of Neuro-Oncology|March 24, 2017
Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survivalMatthew Mason, Catherine Maurice, Mairead G McNamara, et al.
JTO Clinical and Research Reports|September 4, 2023
Management Paradigm of Central Nervous System Metastases in NSCLC: An Australian PerspectiveChee Khoon Lee, Yu Yang Soon, Rosalind L Jeffree, et al.
BMC Cancer|June 2, 2022
Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)Lucy Gately, Katharine Drummond, Mark Rosenthal, et al.
Asia-Pacific Journal of Clinical Oncology|June 24, 2021
Barriers and potential solutions to international collaboration in neuro-oncology clinical trials: Challenges from the Australian perspectiveBenjamin Y Kong, Candace Carter, Anna K Nowak, et al.
Expert Opinion on Investigational Drugs|June 3, 2022
A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancerByoung Chul Cho, Sarah B Goldberg, Dong-Wan Kim, et al.
Cells|January 25, 2020
Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States are Maintained in 3D CultureRochelle C J D'Souza, Carolin Offenhäuser, Jasmin Straube, et al.
Gynecologic Oncology|May 8, 2024
Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 studyAntonio González-Martín, Hyun Cheol Chung, Esma Saada-Bouzid, et al.
Pageof 8